Skip to main content
Clinical Trials/JPRN-UMIN000027209
JPRN-UMIN000027209
Completed
未知

Phase I/II clinical trial of verification for the safety and efficacy of Amitose-Bis-glyceryl ascorbate-containing cream in renal cell carcinoma patients treated by sunitinib - Phase I/II clinical trial of verification for the safety and efficacy of Amitose-Bis-glyceryl ascorbate-containing cream in renal cell carcinoma patients treated by sunitinib

Kobe University Hospital0 sites24 target enrollmentDecember 27, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Renal cell carcinoma
Sponsor
Kobe University Hospital
Enrollment
24
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 27, 2018
End Date
March 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients in whom the underlying disease is a dermatological disease at palmar and planter region at initiation of sunitinib treatment 2\) Patients who are applied external medicine not involving 10% urea and heparinoid\-containing cream to palmar and planter region at initiation of sunitinib treatment 3\) Patients who are not able to apply 10% urea or heparinoid\-containing cream to palmar and planter region 4\) Patients with HFSR of grade 1 or higher at initiation of sunitinib treatment 5\) Patients with infections which needs systemic treatment 6\) Patients with severe hepatic disorder 7\) Patients with severe renal disorder 8\) Patients who are lack of felicity

Outcomes

Primary Outcomes

Not specified

Similar Trials